semaglutide weight loss curve over time following adjunct treatment with Reparameterized semaglutide PD model fits
Description
Is it safe to restart GLP-1s at discharge
Mounjaros dual mechanism of action and its impressive results in clinical trials have positioned it as a promising alternative for patients who may need more robust treatment than what is offered by GLP-1 receptor agonists alone
These innovations may transform metabolic disease treatment over the next decade
Ask about spacing increases to 68 weeks if reflux is severe
